Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8733139 | Health Policy and Technology | 2018 | 8 Pages |
Abstract
Large differences in patient access to ultra-orphan drugs were observed between countries. Future research should examine if similar findings can be seen in other countries and with other orphan drugs, and it should also determine which other factors play a role in reimbursement status of orphan drugs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Health Informatics
Authors
Tim A. Kanters, W. Ken Redekop, Leona Hakkaart,